|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Sage Therapeutics, Inc. (SAGE) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
58,290,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sage Therapeutics is a biopharmaceutical company focused on developing and commercializing medicines with the potential to transform the lives of people with debilitating disorders of the brain. Co.'s principal product, ZULRESSO, is a proprietary intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. Co.'s other product candidate is zuranolone (SAGE-217), an oral compound being developed for certain affective disorders, including major depressive disorder, and PPD. Co. has a portfolio of other compounds that target GABAA receptors, including SAGE-324. SAGE-324 is a GABAA receptor positive allosteric modulator intended for chronic oral dosing.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$37,279 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Quirk Michael C. |
See Remarks |
• – – |
2025-06-24 |
4 |
D |
$9.22 |
$1,042 |
D/D |
(113) |
30,461 |
|
- |
|
| Shiferman Gregory L. |
See Remarks |
• – – |
2025-06-24 |
4 |
D |
$9.22 |
$728 |
D/D |
(79) |
30,950 |
|
- |
|
| Shiferman Gregory L. |
See Remarks |
• – – |
2025-04-10 |
4 |
D |
$6.91 |
$1,216 |
D/D |
(176) |
31,029 |
|
- |
|
| Shiferman Gregory L. |
See Remarks |
• – – |
2025-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
525 |
31,205 |
|
- |
|
| Greene Barry E |
President and CEO |
• • – |
2025-04-10 |
4 |
D |
$6.91 |
$33,596 |
D/D |
(4,862) |
100,169 |
|
- |
|
| Greene Barry E |
President and CEO |
• • – |
2025-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
19,964 |
105,031 |
|
- |
|
| Benecchi Christopher |
Chief Operating Officer |
• – – |
2025-04-10 |
4 |
D |
$6.91 |
$10,047 |
D/D |
(1,454) |
48,428 |
|
- |
|
| Benecchi Christopher |
Chief Operating Officer |
• – – |
2025-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,967 |
49,089 |
|
- |
|
| Quirk Michael C. |
See Remarks |
• – – |
2025-04-10 |
4 |
D |
$6.91 |
$5,086 |
D/D |
(736) |
30,574 |
|
- |
|
| Quirk Michael C. |
See Remarks |
• – – |
2025-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,202 |
30,998 |
|
- |
|
| Quirk Michael C. |
See Remarks |
• – – |
2025-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
27,108 |
|
- |
|
| Quirk Michael C. |
See Remarks |
• – – |
2025-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
29,108 |
|
- |
|
| Shiferman Gregory L. |
See Remarks |
• – – |
2025-02-24 |
4 |
D |
$7.49 |
$18,740 |
D/D |
(2,502) |
30,759 |
|
- |
|
| Gault Laura |
Chief Medical Officer |
• – – |
2025-02-13 |
4 |
D |
$7.18 |
$4,918 |
D/D |
(685) |
34,649 |
|
- |
|
| Benecchi Christopher |
Chief Operating Officer |
• – – |
2025-02-13 |
4 |
D |
$7.18 |
$5,902 |
D/D |
(822) |
43,915 |
|
- |
|
| Shiferman Gregory L. |
See Remarks |
• – – |
2025-02-13 |
4 |
D |
$7.18 |
$4,502 |
D/D |
(627) |
33,261 |
|
- |
|
| Gault Laura |
Chief Medical Officer |
• – – |
2025-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
35,334 |
|
- |
|
| Benecchi Christopher |
Chief Operating Officer |
• – – |
2025-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
44,737 |
|
- |
|
| Shiferman Gregory L. |
See Remarks |
• – – |
2025-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
33,888 |
|
- |
|
| Shiferman Gregory L. |
See Remarks |
• – – |
2024-12-24 |
4 |
D |
$5.48 |
$433 |
D/D |
(79) |
19,888 |
|
- |
|
| Benecchi Christopher |
Chief Operating Officer |
• – – |
2024-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
24,737 |
|
- |
|
| Shiferman Gregory L. |
See Remarks |
• – – |
2024-11-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,967 |
|
- |
|
| Shiferman Gregory L. |
See Remarks |
• – – |
2024-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
19,967 |
|
- |
|
| Cook Anne Marie |
SVP, GC & Secretary |
• – – |
2024-08-05 |
4 |
D |
$8.96 |
$40,347 |
D/D |
(4,503) |
24,040 |
|
- |
|
| Cook Anne Marie |
SVP, GC & Secretary |
• – – |
2024-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
28,543 |
|
- |
|
240 Records found
|
|
Page 1 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
